Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

FDA Drug Recalls

5,405 recalls, newest first

Class I · High risk

Nano PNC Water

Marketed without an Approved NDA/ANDA and non-sterility: NANO PNC Water by nebulizer was sampled and found to contain variovorax paradoxus.

Terminated Sterility / contamination Pacific Medical Solutions D-0505-2017
Class II · Moderate risk

Fluconazole Injection

Lack of Assurance of Sterility: confirmed customer complaints of leaking bags.

Terminated Sterility / contamination Baxter Healthcare Corporation NDC 0338-6046-48 D-0206-2017
Class II · Moderate risk

Lidocaine HCl 1%

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Terminated Sterility / contamination Cantrell Drug Company D-0197-2017
Class II · Moderate risk

Heparin Sodium 5

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Terminated Sterility / contamination Cantrell Drug Company NDC 52533-097-24 D-0193-2017
Class II · Moderate risk

Heparin Sodium

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Terminated Sterility / contamination Cantrell Drug Company NDC 52533-148-16 D-0192-2017
Class II · Moderate risk

Fentanyl Citrate 2

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Terminated Sterility / contamination Cantrell Drug Company NDC 52533-024-61 D-0189-2017
Class II · Moderate risk

Fentanyl Citrate 1

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Terminated Sterility / contamination Cantrell Drug Company NDC 52533-024-35 D-0188-2017
Class II · Moderate risk

Calcium Chloride

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Terminated Sterility / contamination Cantrell Drug Company D-0187-2017
Class II · Moderate risk

Calcium Chloride

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Terminated Sterility / contamination Cantrell Drug Company NDC 52533-102-09 D-0186-2017
Class II · Moderate risk

L-Cysteine Hydrochloride Injection

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.

Terminated Sterility / contamination Sandoz Inc NDC 66758-005-01 D-0141-2017
Class II · Moderate risk

L-Cysteine Hydrochloride Injection

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.

Terminated Sterility / contamination Sandoz Inc NDC 66758-004-01 D-0140-2017

Recalls by year